Application of ivivr in the development of generic transdermal drug delivery system: a case study of rivastigmine
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: EAGA, Chandra Mohan (Hyderabad, India)
- Co-author(s): Aggarwal, Deepika (Dr Reddys Laboratories, Hyderabad, India)
Pk, Ruby (Dr Reddys Laboratories, Hyderabad, India)
Malayandi, Rajkumar (Dr Reddys Laboratories, Hyderabad, India)
Background: Transdermal therapeutic drug delivery systems have been gained more importance in recent years, especially for the delivery of CNS agents, pain management, hormones etc. Rivastigmine, a centrally acting acetylcholine esterase inhibitor is used in the treatment of dementia associated with Alzhemer's disease and Parkinsonism. Oral.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.